GB virus C/hepatitis G virus and TT virus infections among high risk renal transplant recipients in India (Q43046993)

12 November 2017

title

GB virus C/hepatitis G virus and TT virus infections among high risk renal transplant recipients in India (English)

1 reference

12 November 2017

1 reference

GB virus C

1 reference

1

Priya Abraham

1 reference

12 November 2017

7

Gopalan Sridharan

1 reference

12 November 2017

3

Sukanya Raghuraman

1 reference

12 November 2017

George T John

2

1 reference

12 November 2017

Sujatha Radhakrishnan

series ordinal

4

1 reference

12 November 2017

Paulose P Thomas

series ordinal

5

1 reference

12 November 2017

Chacko K Jacob

series ordinal

6

1 reference

12 November 2017

publication date

1 September 2003

1 reference

Journal of Clinical Virology

12 November 2017

published in

1 reference

12 November 2017

volume

28

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

59-69

1 reference

GB virus-C/hepatitis G virus and transfusion-transmitted virus infection in blood donors in a tertiary care hospital in south India

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Detection of HGV in serum and peripheral blood mononuclear cells of maintenance haemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Hepatitis G virus infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Avoiding false positives with PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Improved detection systems for TT virus reveal high prevalence in humans, non-human primates and farm animals

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Infection with hepatitis GB virus C in patients on maintenance hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Transfusion-associated TT virus infection and its relationship to liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

TT virus infection among renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Predictors of GBV-C infection among patients referred for renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Marked genomic heterogeneity and frequent mixed infection of TT virus demonstrated by PCR with primers from coding and noncoding regions

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Clinical and virological profiles in patients with multiple hepatitis virus infections

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Global distribution of transfusion-transmitted virus

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

High prevalence of hepatitis G viremia among kidney transplant patients in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Detection of a novel DNA virus (TTV) in blood donors and blood products.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Isolation of novel virus-like sequences associated with human hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Low prevalence of hepatitis D (delta) virus infection in a nephrology unit in south India

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

Infection with GB virus C (GBV-C) in patients with chronic liver disease or on maintenance hemodialysis in Indonesia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

The prevalence of TT virus infection in renal transplant recipients in Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2802%2900239-1

7 January 2021

10.1016/S1386-6532(02)00239-1

Identifiers

DOI

1 reference

12 November 2017

1 reference